Neurological History-Taking

Presenting Complaints

Headache
Onset, severity, location, aggravating / relieving, prodromal symptoms
Seizure
Witnessed, duration, LOC, collateral
Presyncope / Syncope
Lightheadedness / loss of consciousness
Visual Changes
Blurring, diplopia, amaurosis fugax
Visual Blurring
Onset, use of glasses
Diplopia
Onset, associated symptoms
Amaurosis Fugax
Temporary visual loss without pain
Olfactory Changes
Loss of olfactory sensation, altered olfaction
Hearing Changes
Tinnitus, hearing loss
Tinnitus
Constant or intermittent, triggers
Hearing Loss
Degree of hearing loss, impact on function
Vertigo
Room spinning or patient spinning
Muscular Symptoms
Weakness, spasm, tremor, facial droop
Muscle Weakness
Proximal or distal
Muscle Spasm
Which muscles, situation
Tremor
Resting or with activity
Facial Droop
Onset, associated symptoms
Sensory Changes
Loss of sensation / tingling / burning
Numbness
Location, constant or intermittent
Paraesthesia
Pins & needles

Location, constant or intermittent
Neck Stiffness
Fevers, headache, photophobia
Dysarthria
Difficulty articulating

Onset, associated symptoms

Further History

Handedness
± Footedness
Description of a Single Episode
Before, during, after
Pattern of Events Over Time
First event, max frequency, Sx-free interval
Circumstances of Attacks
Precipitants, aggravators, alleviators
Trauma
Cerebral, neck or back

Past Medical History

Cerebrovascular Events
TIA / stroke

How many, when, functional residual
Epilepsy
Frequency / last seizure, type of seizures
Migraines
Frequency, severity, symptoms, impact
Multiple Sclerosis
Family history, relapses, management
Parkinson's Disease
Symptoms, dopamine replacement regimen
Motor Neuron Disease
Clinical phenotype, manifestations, management, prognosis
Myaesthenia Gravis
Symptoms, past myaesthenic crisis
Cerebrovascular Risk Factors
IHD, AF, HTN, lipids, Diabetes
Ischaemic Heart Disease
When diagnosed, symptoms, past coronary events, echo / angio results, management
Atrial Fibrillation
Paroxysmal / constant, CHADS2, anticoagulation, past TIA / stroke
Diabetes
Diagnosis, control, management, complications
Hyperlipidaemia
When diagnosed, lipid results, meds, diet
Hypertension
Latest BP readings, meds, complications

Medications

Family History

Known Family Neurological History
Family tree, age of onset

Social History

Education
Level of education attained
Vocation
Toxin exposure
Recent Travel
Where, when, how long
Degree of Support Available
Physically and psychologically
Impact of Presenting Complaint
On relationships, work etc.

Substance History

Alcohol
Average per day / week
Smoking
Pack-years, years since quitting
Recreational drugs
Acute intoxication
Illicit drug use, alcohol, opiates, methamphetamine etc
Withdrawal
Recently ceased drugs

Read More...

Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2007 Jun;61(6):504-13.

Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. The Lancet Neurology. 2015 Mar 1;14(3):263-73.

Dharmadasa T, Henderson RD, Talman PS, Macdonell RA, Mathers S, Schultz DW, Needham M, Zoing M, Vucic S, Kiernan MC. Motor neurone disease: progress and challenges. Medical Journal of Australia. 2017 May;206(8):357-62.

Ferlisi M, Shorvon S. Seizure precipitants (triggering factors) in patients with epilepsy. Epilepsy & Behavior. 2014 Apr 1;33:101-5.

Hajat C, Dundas R, Stewart JA, Lawrence E, Rudd AG, Howard R, Wolfe CD. Cerebrovascular Risk Factors and Stroke Subtypes: Differences Between Ethnic Groups. Stroke. 2001; 32: 37-42. Link

Hayes MW, Fung VS, Kimber TE, O'Sullivan JD. Current concepts in the management of Parkinson disease. Medical Journal of Australia. 2010 Feb;192(3):144-9.

Jankovic J. Parkinson’s disease: clinical features and diagnosis. Journal of neurology, neurosurgery & psychiatry. 2008 Apr 1;79(4):368-76.

Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. InSeminars in neurology 2004 Mar (Vol. 24, No. 01, pp. 75-81). Copyright© 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA..

Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine. 2004 Apr;29(4):484-505.

Kennedy A, Zakaria R. Taking a Neurological History. Medicine. 2006; 36(10): 509-514. Link

Lima, Marco A. What is the essential neurological examination?. Arquivos de neuro-psiquiatria. 2012 Dec; 70(12): 939. Link

McDermott CJ, Shaw PJ. Diagnosis and management of motor neurone disease. Bmj. 2008 Mar 20;336(7645):658-62.

Murthy JM, Meena AK, Chowdary GV, Naryanan JT. Myasthenic crisis: clinical features, complications and mortality. Neurology India. 2005 Jan 1;53(1):37.

O'Brien MD. Taking a Neurological History. The Foundation Years. 2006; 2(1): 1-6. Link

Palace J. Making the diagnosis of multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry. 2001 Dec 1;71(suppl 2):ii3-8.

Pearl PL. Neurological Problems of Jazz Legends. Journal of Child Neurology. 2009 Aug; 24(8): 1037-1042. Link

Perlmutter JS. Assessment of Parkinson disease manifestations. Current protocols in neuroscience. 2009 Oct;49(1):10-.

Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016 Jul 26;87(4):419-25.

Shorvon SD. The etiologic classification of epilepsy. Epilepsia. 2011 Jun;52(6):1052-7.

Simpson S, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry. 2011 Oct 1;82(10):1132-41.

Talbot K. Motor neurone disease. Postgraduate medical journal. 2002 Sep 1;78(923):513-9.